SEI Investments’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
SEI Investments's BLUE Position: Q2 2022 in Review
SEI Investments sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 788 shares — an estimated $28K sold.
SEI Investments first reported a position in BLUE in Q4 2014 and held it in 26 quarters. The position peaked at $2.75M in Q2 2018. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- SEI Investments reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
- SEI Investments sold 788 bluebird bio shares in Q2 2022, an estimated $28K.
- SEI Investments first reported a position in bluebird bio in Q4 2014 and held it in 26 quarters.
- SEI Investments's bluebird bio position peaked at $2.75M in Q2 2018.
- 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on SEI Investments's 13F filing for Q2 2022, filed 15 Aug 2022.